Drug Shortage Report for ROPIVACAINE HYDROCHLORIDE INJECTION, USP

Last updated on 2020-01-16 History
Report ID 90057
Drug Identification Number 02439379
Brand name ROPIVACAINE HYDROCHLORIDE INJECTION, USP
Common or Proper name Ropivacaine
Company Name FRESENIUS KABI CANADA LTD
Active Ingredient(s) ROPIVACAINE HYDROCHLORIDE
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration EPIDURAL INFILTRATION
Packaging size 200mL Freeflex bag
ATC code N01BB
ATC description ANESTHETICS, LOCAL
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-07-26
Estimated end date 2019-10-31
Actual end date 2020-01-03
Shortage status Resolved
Updated date 2020-01-16
Company comments Available from January 3, 2020
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2020-01-16 French Compare
v10 2020-01-16 English Compare
v9 2019-10-01 French Compare
v8 2019-10-01 English Compare
v7 2019-09-13 French Compare
v6 2019-09-13 English Compare
v5 2019-08-23 French Compare
v4 2019-08-23 English Compare
v3 2019-07-27 English Compare
v2 2019-07-26 French Compare
v1 2019-07-26 English Compare